Have You Herd? AABP PodCasts - Understanding Compounding Medication for Use in Food Animals

November 29, 2022 — 

AABP Executive Director Dr. Fred Gingrich is joined by AABP Past President Dr. Mike Apley, a clinical pharmacologist from Kansas State University. Apley discusses the FDA Guidance for Industry (GFI) #256.

Apley also discusses a document that was produced in collaboration with the American Association of Swine Veterinarians that can be at https://aasv.org/documents/azuril.pdf. This document discusses the legalities of using compounded products, specifically ponazuril, diclazuril and toltrazuril for the treatment of coccidiosis. Veterinarians can prescribe ponazuril for ELDU as long as all parts of AMDUCA are met and they are using the FDA approved equine product. Diclazuril is a feed pellet and extra-label use of this product in feed is prohibited. Toltrazuril has no approved product in the US and would be prohibited to use. Apley reminds us that veterinarians are the responsible party for ensuring legal and judicious drug use when considering extra-label use and be aware of the prohibition of using bulk compounded products in food animals that are not on the FDA list of poison antidotes.

Listen to this episode directly at https://www.buzzsprout.com/814177/11716367-understanding-compounding-medication-for-use-in-food-animals, and search for other AABP Have You Herd? podcasts at https://www.buzzsprout.com/814177; listen on your favorite podcast platform.